
Medicine and Health
speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing
R. Castellanos-rueda, R. B. D. Roberto, et al.
This groundbreaking research by Rocío Castellanos-Rueda, Raphaël B. Di Roberto, and others showcases speedingCARs, a novel method that utilizes engineered chimeric antigen receptors for enhanced T cell responses against tumors. By integrating a diverse library of CAR variants into human T cells, the study identifies potentiated tumor-killing properties through advanced sequencing techniques, paving the way for innovative cancer therapies.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.